Early Pregnancy Clinical Trial
Official title:
Effects of Vitamin B12 Fortified Milk Supplementation During Pregnancy and 6 Month Postpartum to Improve B12 Status and Child Development
Impaired vitamin B12 (B12) status during pregnancy is associated with increased risk of birth defects and common complications (e.g. intrauterine growth restriction, neural tube defects), and possibly immune function impairment. The newborns and infants of B12-deficient mothers have low B12 stores at birth, further exacerbated by a very low concentration of B12 in breast milk that may hinder their growth and development. In regions such as Bangladesh, many women of reproductive age have inadequate B12 status, probably due to low intake of animal source food. Vitamin B12 intake and status in pregnancy and lactation is potentially insufficient to prevent impaired child development and immune function related to inadequate B12 status. The investigators hypothesize that prolonged vitamin B12 supplementation through fortified milk starting from early pregnancy up to 6 mo-postpartum will improve: (1) biomarkers of vitamin B12 status in mothers-infant pairs (2) vaccine specific adaptive immunity in infants; (3) neurological and cognitive function in infants.
The investigators aim to conduct a double-blind, randomized trial, to investigate the effects of B12-fortified milk on maternal and infant B12 status, immune function and child development. Pregnant women (n=148) will be randomized to receive B12-fortified milk (100 μg/day) or milk without fortification. The daily supplementation beginning at the baseline visit (GW 11-14) will continue until 6 mo-postpartum. Biomarkers of B12 status will be measured in mothers (GW 11-14 and 6-mo postpartum) and infants (3 and 6-mo). Infant development (6 and 12-mo) will be evaluated by Bayley Scales of Infant and Toddler Development. Immune responses will be measured in infant at 3 and 6-mo. Data on socioeconomic status, dietary diversity, and anthropometric indices will be recorded at baseline. Additional tests in mothers include screening for H. pylori and plasma gastrin. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT01639989 -
Doppler Assesment of Blood Flow in the Spiral Arteries
|
N/A | |
| Recruiting |
NCT06002412 -
Quality Control of Ultrasound Images During Early Pregnancy Via AI
|
||
| Completed |
NCT04152278 -
Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
|
||
| Completed |
NCT03161873 -
Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
|
||
| Active, not recruiting |
NCT03440866 -
Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion.
|
N/A | |
| Completed |
NCT02979834 -
When Will I Feel The First Movements of My Baby?
|
N/A | |
| Terminated |
NCT02847910 -
ClinicaI Observation of Induced Abortion With Disposable Tissue Suction Tube
|
N/A | |
| Completed |
NCT04371991 -
Kisspeptin Levels in Early Pregnancy
|
||
| Active, not recruiting |
NCT05142020 -
Biomarkers for Early Screening of Gestational Diabetes Mellitus
|
||
| Recruiting |
NCT04717661 -
A Diagnostic Test Study of Characteristic Sound Waves in Radial Artery of Early Pregnant Women
|
||
| Completed |
NCT05484869 -
Very Advanced Maternal Aged Pregnants and Early Adolescent Pregnant Women
|
||
| Recruiting |
NCT04738370 -
Assessment of Biomarkers in Pregnancy on Unknown Location and Ectopic Pregnancy
|
||
| Completed |
NCT06228118 -
Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System
|
||
| Completed |
NCT06228131 -
Detection of hCG in Early Pregnancy Clinical Samples
|
||
| Active, not recruiting |
NCT04388605 -
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
|
||
| Completed |
NCT00340782 -
Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala
|
N/A |